{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:45:21Z","timestamp":1776401121510,"version":"3.51.2"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"D1","license":[{"start":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T00:00:00Z","timestamp":1510358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,4]]},"DOI":"10.1093\/nar\/gkx1088","type":"journal-article","created":{"date-parts":[[2017,10,22]],"date-time":"2017-10-22T11:06:59Z","timestamp":1508670419000},"page":"D1137-D1143","source":"Crossref","is-referenced-by-count":88,"title":["SuperDRUG2: a one stop resource for approved\/marketed drugs"],"prefix":"10.1093","volume":"46","author":[{"given":"Vishal B","family":"Siramshetty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver Andreas","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn-Oliver","family":"Gohlke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrean","family":"Goede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaofeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashanth","family":"Devarakonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Preissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Preissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,11,11]]},"reference":[{"key":"key\n\t\t\t\t20180103185627_B1","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B2","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1093\/nar\/gkr988","article-title":"KEGG for integration and interpretation of large-scale molecular data sets","volume":"40","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B3","doi-asserted-by":"crossref","first-page":"D1214","DOI":"10.1093\/nar\/gkv1031","article-title":"ChEBI in 2016: Improved services and an expanding collection of metabolites","volume":"44","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B4","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B5","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","article-title":"The ChEMBL bioactivity database: an update","volume":"42","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B6","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B7","doi-asserted-by":"crossref","first-page":"D1128","DOI":"10.1093\/nar\/gkr797","article-title":"Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery","volume":"40","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B8","doi-asserted-by":"crossref","first-page":"D972","DOI":"10.1093\/nar\/gkw838","article-title":"The Comparative Toxicogenomics Database: update 2017","volume":"45","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B9","doi-asserted-by":"crossref","first-page":"D932","DOI":"10.1093\/nar\/gkw993","article-title":"DrugCentral: online drug compendium","volume":"45","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1107\/S0108768102003890","article-title":"The Cambridge Structural Database: a quarter of a million crystal structures and rising","volume":"58","year":"2002","journal-title":"Acta Crystallogr. B."},{"key":"key\n\t\t\t\t20180103185627_B12","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/bioinformatics\/bts186","article-title":"e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design","volume":"28","year":"2012","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20180103185627_B13","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/bioinformatics\/bti295","article-title":"SuperDrug: a conformational drug database","volume":"21","year":"2005","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20180103185627_B14","doi-asserted-by":"crossref","first-page":"D1080","DOI":"10.1093\/nar\/gkv1192","article-title":"WITHDRAWN\u2013a resource for withdrawn and discontinued drugs","volume":"44","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/bioinformatics\/btu829","article-title":"3Dmol.js: molecular visualization with WebGL","volume":"31","year":"2015","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20180103185627_B16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12916-016-0553-2","article-title":"Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature","volume":"14","year":"2016","journal-title":"BMC medicine"},{"key":"key\n\t\t\t\t20180103185627_B17","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1021\/ci5005509","article-title":"Influence of search parameters and criteria on compound selection, promiscuity, and pan assay interference characteristics","volume":"54","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"key\n\t\t\t\t20180103185627_B18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature11159","article-title":"Large-scale prediction and testing of drug activity on side-effect targets","volume":"486","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180103185627_B19","doi-asserted-by":"crossref","first-page":"W26","DOI":"10.1093\/nar\/gku477","article-title":"SuperPred: update on drug classification and target prediction","volume":"42","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1021\/ci025584y","article-title":"The Chemistry Development Kit (CDK): an open-source Java library for Chemo- and Bioinformatics","volume":"43","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"key\n\t\t\t\t20180103185627_B21","first-page":"922","article-title":"A solution for the best rotation to relate two sets of vectors","volume":"A32","year":"1976","journal-title":"Acta Cryst."},{"key":"key\n\t\t\t\t20180103185627_B22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12859-015-0730-x","article-title":"2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug Vatalanib","volume":"16","year":"2015","journal-title":"BMC Bioinformatics"},{"key":"key\n\t\t\t\t20180103185627_B23","doi-asserted-by":"crossref","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","article-title":"The SIDER database of drugs and side effects","volume":"44","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B24","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/cc11441","article-title":"Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics","volume":"16","year":"2012","journal-title":"Crit. Care"},{"key":"key\n\t\t\t\t20180103185627_B25","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults","volume":"63","author":"By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","journal-title":"J. Am. Geriatr. Soc."},{"key":"key\n\t\t\t\t20180103185627_B26","first-page":"543","article-title":"Potentially inappropriate medications in the elderly: the PRISCUS list","volume":"107","year":"2010","journal-title":"Deutsches Arzteblatt Int."},{"key":"key\n\t\t\t\t20180103185627_B27","doi-asserted-by":"crossref","first-page":"41307","DOI":"10.18632\/oncotarget.5846","article-title":"E7449: A dual inhibitor of PARP1\/2 and tankyrase1\/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling","volume":"6","year":"2015","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20180103185627_B28","doi-asserted-by":"crossref","first-page":"D1113","DOI":"10.1093\/nar\/gkt1246","article-title":"The Transformer database: biotransformation of xenobiotics","volume":"42","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20180103185627_B29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2002.121216","article-title":"Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype","volume":"71","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"key\n\t\t\t\t20180103185627_B30","first-page":"1051","article-title":"Role of CYP2C9 polymorphism in losartan oxidation","volume":"29","year":"2001","journal-title":"Drug Metab. Disposition"},{"key":"key\n\t\t\t\t20180103185627_B31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000368513","article-title":"Treatment of hypertension: favourable effect of the twice-daily compared to the once-daily (evening) administration of perindopril and losartan","volume":"40","year":"2015","journal-title":"Kidney Blood Pressure Res."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/46\/D1\/D1137\/23162270\/gkx1088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T00:11:33Z","timestamp":1570234293000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/nar\/article\/46\/D1\/D1137\/4616872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,11]]},"references-count":31,"journal-issue":{"issue":"D1","published-online":{"date-parts":[[2017,11,11]]},"published-print":{"date-parts":[[2018,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkx1088","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1,4]]},"published":{"date-parts":[[2017,11,11]]}}}